ticlopidine has been researched along with Hyperlipoproteinemia Type II in 2 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Hyperlipoproteinemia Type II: A group of familial disorders characterized by elevated circulating cholesterol contained in either LOW-DENSITY LIPOPROTEINS alone or also in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamamoto, H | 1 |
| Takada, T | 1 |
| Yamanashi, Y | 1 |
| Ogura, M | 1 |
| Masuo, Y | 1 |
| Harada-Shiba, M | 1 |
| Suzuki, H | 1 |
| Di Minno, G | 1 |
| Cerbone, AM | 1 |
| Iride, C | 1 |
| Mattioli, PL | 1 |
| Postiglione, A | 1 |
| Mancini, M | 1 |
2 other studies available for ticlopidine and Hyperlipoproteinemia Type II
| Article | Year |
|---|---|
VLDL/LDL acts as a drug carrier and regulates the transport and metabolism of drugs in the body.
Topics: Amlodipine; Animals; Biological Transport; Cholesterol; Drug Carriers; Hyperlipoproteinemia Type II; | 2017 |
Platelet fibrinogen binding in familial hypercholesterolemia.
Topics: Adenosine Diphosphate; Adolescent; Adult; Blood Platelets; Child; Female; Fibrinogen; Humans; Hyperl | 1987 |